Ashvinikumar V. Gavai

Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors

Ashvinikumar V. Gavai, Claude Quesnelle, Derek Norris et al. · ACS Medicinal Chemistry Letters · 2015 · 89 citations · Full text

Medicine, Medicinal Chemistry, Oncology +11

Enantioselective route to a key intermediate in the total synthesis of ginkgolide B

E. J. Corey, Ashvinikumar V. Gavai · Tetrahedron Letters · 1988 · 88 citations

Pharmacy, Medicinal Chemistry, Drug Discovery +6

Preclinical Antitumor Activity of BMS-599626, a pan-HER Kinase Inhibitor That Inhibits HER1/HER2 Homodimer and Heterodimer Signaling

Tai W. Wong, Francis Y. Lee, Chiang Yu et al. · Clinical Cancer Research · 2006 · 79 citations

Medicine, Medicinal Chemistry, Oncology +13

A (Z)-ethylidenecyclopentane annulation method. Total syntheses of (.+-.)-anhydrooplopanone, (.+-.)-oplopanone, and (.+-.)-8-epi-oplopanone

Edward Piers, Ashvinikumar V. Gavai · The Journal of Organic Chemistry · 1990 · 45 citations

Natural Sciences, Chemistry, Drug Discovery +6

Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design

Ashvinikumar V. Gavai, Derek Norris, George V. Delucca et al. · Journal of Medicinal Chemistry · 2021 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17